The problem of Pseudomonas aeruginosa antibiotic-resistance and search of effective means of fighting
Journal Title: Бюлетень "Ветеринарна біотехнологія" - Year 2018, Vol 32, Issue
Abstract
Introduction. Pseudomonas aeruginosa (P. aeruginosa) is one of the “traditional” pathogens of purulent-septic diseases and complications, which causes about 30–70% of nosocomial infection cases. The causative agent has many pathogenicity factors and a complex of mechanisms for the development of resistance to antibiotics. P. аeruginosa is a pathogen for humans, animals and plants. Pseudomonosis is an acute contagious infectious disease of agricultural animals, fur animals, pets, birds, foxes, arctic foxes and fish. P. aeruginosa causes an infectious disease of young animals in the form of septicemia, toxemia with high mortality, and embryos death mainly in the last days of incubation. In adult animals Pseudomonas infection is characterized by the development of septicemia, pneumonia, encephalitis, aerosaculate, conjunctivitis, necrotic dermatitis, arthritis, hepatitis. The disease causes significant economic losses in livestock and poultry. The goal of the work was to study antibiotic resistance of P. aeruginosa in humane and veterinary medicine and research the effectiveness of the proposed anti–bacterial preparation Saroflox towards to P. aeruginosa. Materials and methods. Sensitivity of P. aeruginosa isolates to antibacterial preparations was determined by diffusion method in agar. The effectiveness of the proposed experimental antibiotic “Saroflox” against the isolates of P. aeruginosa was determined by the method of serial dilutions in a liquid nutrient medium – meat-pumped broth in comparison with enrofloxacin. Results of research and discussion. The presence of P. aeruginosa in the smears from the objects of the hospital environment (inpatient hospital, maternity hospital) and poultry farms (hatchery, chicken breeding department) has been confirmed. The polyresistance of P. aeruginosa isolates to antibacterial preparations has been established. A tendency to decrease in the sensitivity of the pathogen against the preparation of the group of cephalosporins, fluoroquinolones, aminoglycosides has been confirmed. Conclusions and prospects for further research. The effectiveness of the proposed anti–bacterial preparation Saroflox against P. aeruginosa in the concentrations from 0.078 to 10% and its more pronounced activity compared to enrofloxacin has been established.
Authors and Affiliations
Tatyana Fotina, Yevgenia Vashchyk, Roman Shcherbyna
Keywords
Related Articles
- EP ID EP407680
- DOI 10.31073/vet_biotech32(2)-70
- Views 137
- Downloads 0
Improvement of ukrainian black and white dairy cattle under conditions of Ternopil oblast in the process of herds consolidation and forming of desirable dairy type of cows
Introduction. The issue of improving Ukrainian black and white dairy cattle is relevant today. It could be solved by the development of the best practices for the preservation of the gene pool, improvement of the herd’s...
Biotic relations of Fusobacterium necrophorum in microbial associations in vitro
Introduction. Scientific and practical studies on the study of the biotic properties of associations of microorganisms in vitro, namely, their qualitative and quantitative composition, the ratio of bacterial species and...
Research on species composition of microflora in poultry farms of different type
Introduction. For the successful development of poultry farming, control of the epizootic situation, study of the species composition of the microflora in poultry farms of different types and technological directions is...
Quality and safety of raw cow’s milk in private farms
Introduction. Increased microbial contamination of raw milk is the result of non-compliance with the sanitation requirements of its obtaining, primary processing, cooling, storage and transportation. Analysis of the raw...
Trichomoniasis of domestic dogs and cats
Introduction. Trichomoniasis of small pets is geographically wide spread common disease, there is evidence of detection of Trichomonas spp. in Europe, North America, Asia, Australia and Oceania. But there is no informati...